Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS - Narrative (Details)

v3.23.3
FAIR VALUE MEASUREMENTS - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Schedule of Equity Method Investments [Line Items]        
Impairment loss $ 3,705 $ 0 $ 3,705 $ 0
Cansativa        
Schedule of Equity Method Investments [Line Items]        
Impairment loss $ 3,705   $ 3,705